picibanil and Cystadenoma

picibanil has been researched along with Cystadenoma* in 1 studies

Other Studies

1 other study(ies) available for picibanil and Cystadenoma

Article	Year
Pseudomyxoma peritonei: effect of chronic continuous immunotherapy with a streptococcal preparation, OK-432 after surgery. Acta obstetricia et gynecologica Scandinavica, 1986, Volume: 65, Issue:2 Three cases of pseudomyxoma peritonei with ovarian neoplasma were treated by adjunctive immunotherapy with OK-432 after surgery. In 2 of the 3 cases, the periods of intramuscular injection of OK-432 were 11 and 16 months, respectively, and the 2 patients remain clinically free from evidence of disease, 7 and 6 years after surgery. The third patient is still undergoing treatment, with no evidence of recurrence at 4 months after surgery. These results, although for a small number of patients, clearly suggest that adjunctive immunotherapy with OK-432 may be suitable for treating pseudomyxoma peritonei of ovarian tumor origin. Topics: Aged; Biological Products; Cystadenoma; Epithelium; Female; Humans; Immunotherapy; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Picibanil; Skin Tests	1986

Article

Year

Pseudomyxoma peritonei: effect of chronic continuous immunotherapy with a streptococcal preparation, OK-432 after surgery.

Acta obstetricia et gynecologica Scandinavica, 1986, Volume: 65, Issue:2

Three cases of pseudomyxoma peritonei with ovarian neoplasma were treated by adjunctive immunotherapy with OK-432 after surgery. In 2 of the 3 cases, the periods of intramuscular injection of OK-432 were 11 and 16 months, respectively, and the 2 patients remain clinically free from evidence of disease, 7 and 6 years after surgery. The third patient is still undergoing treatment, with no evidence of recurrence at 4 months after surgery. These results, although for a small number of patients, clearly suggest that adjunctive immunotherapy with OK-432 may be suitable for treating pseudomyxoma peritonei of ovarian tumor origin.

Topics: Aged; Biological Products; Cystadenoma; Epithelium; Female; Humans; Immunotherapy; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Picibanil; Skin Tests

1986